Long-lasting effect of cyclosporin-a on anemia associated with idiopathic myelofibrosis

Haematologica

Volumn 82, Issue 4, 1997, Pages 458-459

  Pietrasanta, Daniela ^a   Clavio, Marino ^a   Vallebella, Emanuela ^a   Beltrami, Germana ^a   Cavaliere, Marina ^a   Gobbi, Marco ^a,b  

^a UNIVERSITY OF GENOA   (Italy)

^b Department of Hematology DIMI ^*  (Italy)

Author keywords

Anemia; Cyclosporin A; Idiopathic myelofibrosis

Indexed keywords

CYCLOSPORIN A;

AGED; ANEMIA; ARTICLE; BLOOD TRANSFUSION; CASE REPORT; DRUG EFFECT; HUMAN; IDIOPATHIC DISEASE; IMMUNOSUPPRESSIVE TREATMENT; MALE; MYELOFIBROSIS; NEPHROTOXICITY; PATHOGENESIS; STEM CELL;

AGED; ANEMIA; CYCLOSPORINE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MYELOFIBROSIS; TIME FACTORS;

EID: 0031468594     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Geary CG. Clinical and haematological aspects of chronic myelofibrosis. In: Lewis SM, ed. Myelofibrosis: Pathophysiology and Clinical Management New York: Marcel Dekker; 1985. p. 15-47.
2. Lewis CM, Pegrum GD. Immunocomplexes in myelofibrosis: a possible guide to management. Br J Haematol 1977; 39:233-9.
3. Centenara E, Guarnone R, Barosi G. Ciclosporina-A (Cy-A) nell'anemia della mielofibrosi con metaplasia mieloide (MMM). Riassunti 35° Congresso Nazionale Società Italiana di Ematologia, 1994. p. 147.
4. Hasselbach H, Jans H, Nielsen PL A distinct subtype of idiopathic myelofibrosis with bone marrow features mimicking hairy cell leukemia: evidence of an autoimmune pathogenesis. Am J Hematol 1987; 25:225-9.
5. Reilly JT. Pathogenesis of idiopathic myelofibrosis: present status and future directions. Br J Haematol 1994; 88:1-8.
6. Rondeau E, Solal Seligny P, Dhermy D, et al. Immune disorders in agnogenic myeloid metaplasia: relations to myelofibrosis. Br J Haematol 1982; 53:467-75.
7. Gordon BR, Colman M, Kohen P, Day NK. Immunologic abnormalities in myelofibrosis with activation of the complement system. Blood 1981; 58:904-10.
8. Caligaris Cappio F, Vigliani R, Novarino A, Camussi G, Campana D, Gavosto F. Idiopathic myelofibrosis: a possible role for immunocomplexes in the pathogenesis of bone marrow fibrosis. Br J Haematol 1981; 49:17-21.
9. Leoni P, Rupoli S, Salvi A, Sambo P, Cinciripini A, Gabrielli A. Antibodies against terminal galactosyl α (1-3) galactose epitopes in patients with idiopathic myelofibrosis. Br J Haematol 1993; 85: 313-9.
10. Hashimoto F, Sugiura K, Inoue K, Ikehara S. Enhancing effects of cyclosporin A on hematopoietic progenitors: possible role of CD8+ T cells as negative regulators. Exp Hematol 1994; 22:947-53.
11. Finelli C, Bandini G, Ricci P, et al. Cyclosporin A in idiopathic and CLL-associated pure red cell aplasia. Haematologica 1987; 72:537.
12. Bacigalupo A. Guidelines for the treatment of severe aplastic anaemia. Haematologica 1994; 79:439-44.